Quick Overview
A dual-pathway growth hormone (GH) stimulation system combining a growth hormone-releasing hormone (GHRH) analogue and a selective ghrelin receptor agonist.

Full Research Overview
CJC-1295 (without Drug Affinity Complex, “no DAC”) is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH). It stimulates the anterior pituitary gland to release growth hormone in a pulsatile, physiologically regulated manner.




